Abstract
Background
Multimodal analgesia is crucial for effective postoperative pain management in minor hand surgeries, enhancing patient satisfaction. The use of local wound infiltration with Ketorolac as an adjuvant pain management strategy is proposed for open trigger finger release surgery. This study aims to compare pain scores and functional outcomes between local wound infiltration with Ketorolac and oral non-steroidal anti-inflammatory drugs.
Methods
This study is a double-blind, parallel design, randomized controlled trials. Sixty-nine patients underwent trigger finger surgery between December 2021 and October 2022 were randomized into one of three groups: oral Ibuprofen alone group, local Ketorolac alone group and local Ketorolac with oral Ibuprofen group. The assessment included postoperative numeric rating scale (NRS) pain score, Disabilities of the Arm, Shoulder, and Hand (DASH) score, grip strength, mobility of proximal interphalangeal (PIP) joint. and complications.
Results
NRS pain scores during movement of the operated fingers were significantly lower at 6 hours in local Ketorolac alone group and local Ketorolac with oral Ibuprofen group compared to oral Ibuprofen alone group. However, there were no significant differences between the groups in postoperative DASH scores, grip strength, mobility of PIP joints, and complications.
Conclusions
Local infiltration of Ketorolac is safe for use as an adjuvant postoperative pain management and provides superior pain control during finger movement within the first 6 hours following trigger finger surgery compared to oral NSAIDs.
Clinical trial registration:
Thaiclinicaltrials.org identifier: TCTR20210825002. Registered 25/08/2021. https://www.thaiclinicaltrials.org/show/TCTR20210825002
Trial registration
This clinical trial was registered in the Thai Clinical Trials Registry (TCTR) on 25/08/2021: register number TCTR20210825002. https://www.thaiclinicaltrials.org/show/TCTR20210825002